Skip to main content

Table 4 Association among DM and hyperlipidemia and all-cause mortality*

From: Hyperlipidemia and mortality associated with diabetes mellitus co-existence in Chinese peritoneal dialysis patients

 

Model 1

Model 2

Model 3

Model 4

Coef.

SE

HR

95%CI

Coef.

SE

HR

95%CI

Coef.

SE

HR

95%CI

Coef.

SE

HR

95%CI

Hyperlipidemia group

  

1.0 (ref.)

             

DM group

1.090

0.319

3.01

2.14 to 4.21

0.811

0.238

2.24

1.58 to 3.18

0.811

0.238

2.24

1.58 to 3.18

0.858

0.251

2.37

1.66 to 3.39

Among DM patients

                

The follow-up period

                

Hyperlipidemia (yes/no)

0.434

0.127

1.20

0.91 to 1.61

0.391

0.115

1.08

0.80 to 1.45

0.391

0.121

1.14

0.84 to 1.54

0.369

0.108

1.02

0.73 to 1.43

From 48-moth follow up onwards

                

Hyperlipidemia (yes/no)

1.046

0.306

2.89

1.37 to 6.07

1.046

0.306

2.89

1.34 to 6.22

1.303

0.382

3.60

1.62 to 8.01

1.303

0.382

3.60

1.62 to 8.01

Among non-DM patients

                

Hyperlipidemia (yes/no)

0.366

0.107

1.01

0.82 to 1.51

−0.103

0.095

0.90

0.65 to 1.24

−0.101

0.097

0.91

0.65 to 1.27

−0.170

0.103

0.97

0.70 to 1.35

Among hyperlipidemia patients

                

DM (yes/no)

1.368

0.401

3.78

2.60 to 5.50

0.948

0.278

2.62

1.74 to 3.96

1.024

0.300

2.83

1.86 to 4.30

0.945

0.277

2.61

1.69 to 4.04

  1. *P interaction = 1.000
  2. Model 1, unadjusted; model 2, model 1 plus age, sex, body mass index, systolic BP, diastolic BP, current smoking, current alcohol consumption, 24-h urine volume, hypertension, and pre-existing CVD; model 3, model 2 plus medications; model 4, model 3 plus hemoglobin, serum albumin, serum uric acid, eGFR, cholesterol, triglyceride, high-density lipoprotein, low-density lipoprotein, and hs-CRP
  3. DM diabetes mellitus, CVD cardiovascular disease, BP blood pressure, eGFR estimated glomerular filtration rate, hs-CRP high-sensitivity C-reactive protein, SE standard error, HR hazard ratio, CI confidence interval